AQR CAPITAL MANAGEMENT LLC

Position in TNGX — Tango Therapeutics, Inc.

CIK 1167557 Greenwich, CT

Position in TNGX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,244,420

+$1,515,839 QoQ

Shares Held

107,286

+30.5% QoQ

Ownership

0.074%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. TNGX ranks #86 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,231,008	$951,126,014
2	EXEL	Exelixis, Inc.	13,095,741	$561,676,326
3	INCY	Incyte Corp	5,807,930	$546,642,368
4	BMRN	Biomarin Pharmaceutical Inc	7,676,541	$433,647,798
5	ALNY	Alnylam Pharmaceuticals, Inc.	913,104	$302,118,715
6	JAZZ	Jazz Pharmaceuticals plc	1,338,458	$253,035,481
7	RPRX	Royalty Pharma plc	3,782,038	$181,424,357
8	ROIV	Roivant Sciences Ltd.	5,946,858	$164,727,963

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,244,420	107,286	+30.5%	Shares	Defined	2026-05-15
2025-12-31	$728,581	82,233	+3.9%	Shares	Other	2026-02-17
2025-09-30	$665,069	79,175	+0.3%	Shares	Defined	2025-11-14
2025-06-30	$404,202	78,946	-44.4%	Shares	Other	2025-08-14
2025-03-31	$194,686	142,108	+900.3%	Shares	Defined	2025-05-15
2024-09-30	$109,386	14,206	-31.2%	Shares	Defined	2024-11-14
2024-06-30	$177,185	20,651	-59.5%	Shares	Defined	2024-08-14
2024-03-31	$404,732	50,974	+129.9%	Shares	Defined	2024-05-15
2023-12-31	$219,541	22,176	+0.7%	Shares	Other	2024-02-14
2022-09-30	$79,748	22,030	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.